IP Library › Granted Patent US 7,438,900
Granted Patent B2
US 7,438,900 · App. 10/885,878 · Granted Oct 21, 2008

Dendritic encapsulation of active agents

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,438,900
App. No.
10/885,878
Granted
Oct 21, 2008
Kind
B2
Abstract

A pharmaceutical composition comprising an active agent bound to a scaffold for dendritic encapsulation wherein said scaffold is covalently or non-covalently attached to a polysaccharide. More specifically, the invention is directed to active agent complexes or conjugates which utilize dendritic encapsulation alone or in combination with other delivery systems to improve and target active agent release.

Claims (5)

1. A composition comprising hydrocodone covalently attached to a sugar.

2. The composition of claim 1 wherein said sugar is ribose.

3. The composition of claim 1 wherein said sugar is galactose.

4. The composition of claim 1 wherein said sugar is a disaccharide.

5. The composition of claim 1 wherein said sugar is a mannofuranose.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2020
From: SHIRE LLC
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 054626/0595 →
MERGER Recorded Nov 1, 2007
From: NEW RIVER PHARMACEUTICALS INC.
To: SHIRE LLC
Reel/Frame 020054/0484 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2004
From: PICCARIELLO, THOMAS; MICKLE, TRAVIS; BISHOP, BARNEY
To: NEW RIVER PHARMACEUTICALS INC.
Reel/Frame 016067/0772 →